Our Site
AGC Biologics is constructing a new site in Yokohama, Japan with plans to be GMP-ready in 2027. This site will expand our network capabilities in Japan to meet growing global demand for biopharmaceutical CDMO services by offering cell therapy, mammalian, and mRNA-LNP services. Yokohama has already started offering process development work for cell therapy; and once completed, the site will house one of the largest single-use bioreactor systems for mammalian production in Japan.
Our People
Leaders at the Yokohama site are building a collaborative and forward-looking culture as the site grows and comes fully online. You will join teammates who support one another and value both individual perspectives and shared success. As we continue hiring and expanding our capabilities, our Yokohama team members are united by a strong sense of purpose – working together to bring hope to life.
Our City
Located along the scenic waterfront of Tokyo Bay, Yokohama blends modern city life with rich history and vibrant culture. From the iconic Minato Mirai skyline to historic districts like Yokohama Chinatown, the city offers a wide variety of experiences for residents and visitors alike. With its coastal setting, excellent public transportation, and close proximity to Tokyo, Yokohama provides an ideal balance of dynamic urban energy and refreshing waterfront living.
